Autobacs Seven Co Ltd (JP:9832)
:9832
Want to see JP:9832 full AI Analyst Report?
Top Page
Autobacs Seven Co
(9832)
Select Model
Select Model
Rating:65Neutral
Price Target:
¥1,622.00
▲(3.25% Upside)
Action:Downgraded
Date:05/13/26
The score is driven mainly by solid underlying financial strength (growth plus a strong balance sheet), offset by inconsistent free cash flow. Technicals are currently a headwind with broad weakness versus key moving averages and negative momentum, while a reasonable P/E and ~4% dividend yield provide valuation support.
Positive Factors
Business model & network
Autobacs combines retail sales of consumables with attached installation/maintenance services and franchise income. This integrated model drives repeat visits, raises gross per customer via service attach rates, and leverages private brands for durable margin support and resilience.
Negative Factors
Cash flow volatility & weak FCF
Material swings in operating cash flow and recurring negative free cash flow undermine consistent self-funding. Unreliable cash conversion constrains capital allocation, increases reliance on external financing for growth or distributions, and raises execution risk.
Read all positive and negative factors
Positive Factors
Negative Factors
Business model & network
Autobacs combines retail sales of consumables with attached installation/maintenance services and franchise income. This integrated model drives repeat visits, raises gross per customer via service attach rates, and leverages private brands for durable margin support and resilience.
Read all positive factors
Autobacs Seven Co (9832) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥115.89B
Dividend Yield3.63%
Average Volume (3M)167.22K
Price to Earnings (P/E)14.0
Beta (1Y)0.46
Revenue Growth12.24%
EPS Growth2.56%
CountryJP
Employees4,385
SectorConsumer Cyclical
Sector Strength84
IndustrySpecialty Retail
Share Statistics
EPS (TTM)119.82
Shares Outstanding82,050,100
10 Day Avg. Volume173,620
30 Day Avg. Volume167,220
Financial Highlights & Ratios
PEG Ratio6.17
Price to Book (P/B)0.90
Price to Sales (P/S)0.44
P/FCF Ratio-50.75
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)115.9
Revenue Forecast (FY)¥285.10B
Autobacs Seven Co Business Overview & Revenue Model
Company Description
Autobacs Seven Co. (9832) is a leading Japanese retailer specializing in automotive parts, accessories, and services. Founded in 1947, the company operates a chain of stores under the Autobacs brand, offering a wide range of products including tir...
How the Company Makes Money
Autobacs Seven makes money mainly through its automotive aftermarket retail and related network operations. Key revenue streams include: (1) Retail sales of car用品 (automotive goods) at AUTOBACS stores—sales of consumables and replacement parts suc...
Autobacs Seven Co Financial Statement Overview
Summary
Income Statement
73
Positive
Balance Sheet
84
Very Positive
Cash Flow
54
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 259.74B | 280.06B | 249.53B | 229.86B | 236.24B | 228.59B |
| Gross Profit | 92.86B | 100.14B | 83.24B | 71.02B | 75.60B | 73.36B |
| EBITDA | 20.10B | 13.80B | 18.14B | 13.29B | 16.41B | 16.11B |
| Net Income | 9.40B | 8.35B | 8.13B | 6.36B | 7.24B | 7.01B |
Balance Sheet | ||||||
| Total Assets | 223.23B | 239.90B | 228.17B | 194.95B | 194.33B | 189.91B |
| Cash, Cash Equivalents and Short-Term Investments | 31.13B | 20.29B | 31.29B | 31.30B | 24.57B | 24.80B |
| Total Debt | 34.56B | 41.31B | 37.82B | 9.32B | 12.19B | 10.76B |
| Total Liabilities | 91.43B | 103.28B | 96.20B | 65.79B | 67.36B | 67.02B |
| Stockholders Equity | 131.41B | 136.25B | 131.81B | 128.84B | 126.62B | 122.55B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.42B | -4.98B | 5.28B | 3.50B | -588.00M |
| Operating Cash Flow | 0.00 | 14.59B | 3.94B | 14.43B | 10.69B | 5.71B |
| Investing Cash Flow | 0.00 | -23.18B | -18.02B | -449.00M | -7.65B | -7.71B |
| Financing Cash Flow | 0.00 | -2.70B | 13.97B | -7.41B | -3.50B | -12.30B |
Autobacs Seven Co Technical Analysis
Negative
1571.00
Price Trends
1546.76
Negative
1593.21
Negative
1563.83
Negative
Market Momentum
-23.25
Negative
41.20
Neutral
42.55
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9832, the sentiment is Negative. The current price of 1571 is above the 20-day moving average (MA) of 1499.50, above the 50-day MA of 1546.76, and above the 200-day MA of 1563.83, indicating a bearish trend. The MACD of -23.25 indicates Negative momentum. The RSI at 41.20 is Neutral, neither overbought nor oversold. The STOCH value of 42.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:9832.
Autobacs Seven Co Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥438.72B | 10.66 | ― | 1.35% | 15.16% | 20.54% | |
72 Outperform | ¥2.31B | 5.24 | ― | 1.92% | 10.87% | 64.30% | |
67 Neutral | ¥311.87B | 20.85 | ― | 2.72% | 2.94% | 63.59% | |
66 Neutral | ¥304.36B | 15.56 | 11.17% | 2.61% | 5.12% | 12.69% | |
65 Neutral | ¥115.89B | 13.96 | 7.75% | 3.63% | 12.24% | 2.56% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | ¥522.20B | 28.96 | 4.18% | 2.57% | 3.85% | -43.62% |
* Consumer Cyclical Sector Average
JP:9832
Autobacs Seven Co
1,487.00
96.82
6.96%
JP:3048
BIC Cameras
1,778.00
325.40
22.40%
JP:9831
Yamada Denki Co
624.50
207.47
49.75%
JP:2666
Autowave Co., Ltd.
160.00
17.77
12.49%
JP:7419
Nojima Co Ltd
1,433.00
521.24
57.17%
JP:8282
K'S Holdings Corporation
2,096.00
750.41
55.77%
Autobacs Seven Co Corporate Events
Autobacs Seven Posts Modest April Sales Growth on Steady Maintenance Demand
May 12, 2026
Autobacs Seven reported that in April 2026 domestic same-store sales rose 1.6% and total-store sales increased 2.4% year on year, indicating modest growth in its core automotive aftermarket business. The company said maintenance items like tires, ...
Autobacs Seven lifts sales and profit, keeps dividend steady while guiding for further growth
May 11, 2026
Autobacs Seven Co., Ltd. reported consolidated net sales of ¥280.1 billion for the fiscal year ended March 31, 2026, up 12.2% year on year, with operating profit rising 13.8% to ¥13.8 billion and profit attributable to owners of parent i...
Autobacs Denies Final EV Deal with Chery, Reaffirms ZEV Growth Strategy
May 11, 2026
Autobacs Seven clarified that, while it has invested in Singapore-based Electric Mobility Technology, no concrete decisions have been made on selling China-made electric vehicles in Japan in partnership with Chery Automobile, contrary to implicati...
Autobacs Seven Posts Slight March Sales Decline as Accessories Weaken
Apr 7, 2026
Autobacs Seven Co. reported that in March 2026 domestic same-store sales fell 1.0% year on year, while total-store sales slipped 0.2%, reflecting a slight softening in demand. The company said sales of core maintenance items such as tires, oil and...
Autobacs Seven Sets 2026 Board Slate, Balancing Continuity and Renewal
Mar 26, 2026
Autobacs Seven’s board has approved a slate of director candidates to be submitted at the 79th Ordinary General Meeting of Shareholders scheduled for late June 2026. The lineup includes the reappointment of CEO Yugo Horii and other incumbent...
Autobacs Seven posts modest February sales growth on maintenance and car trade demand
Mar 6, 2026
Autobacs Seven reported that in February 2026 domestic same-store sales rose 0.2% year on year, while total-store sales increased 1.2%, reflecting modest growth in its core automotive retail and service operations. The performance was driven mainl...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.